Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
about
A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive declineA Role for the Brain RAS in Alzheimer's and Parkinson's DiseasesRelationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical TrialsAntihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.Memory is preserved in older adults taking AT1 receptor blockers.Additive effects of cilnidipine, an L-/N-type calcium channel blocker, and an angiotensin II receptor blocker on reducing cardiorenal damage in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes mellitus.An update on the diagnosis and management of dementing conditionsEprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR studyBlockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.A Comparison of Cognitive and Everyday Functional Performance among Older Adults With and Without Hypertension.Targeting the neurovascular unit for treatment of neurological disorders.Potential for specific dihydropyridine calcium channel blockers to have a positive impact on cognitive function in humans: a systematic review.Treatment options and considerations for hypertensive patients to prevent dementia.Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.ACEI and ARB did not Reduce the Incidence of Dementia in Patients with Atrial Fibrillation: A Nationwide Cohort StudyEffects of centrally acting ACE inhibitors on the rate of cognitive decline in dementiaAngiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?Non-adherence to antihypertensive medication and impaired cognition: which comes first?Epidemiological findings of vascular risk factors in Alzheimer's disease: implications for therapeutic and preventive intervention.The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.Antihypertensives, angiotensin, glucose and Alzheimer's disease.Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease? Part II: Management, prevention and future perspective.Antihypertensive Therapies and Cognitive Function: a Review.Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.Kicking the tyres of a heart failure trial: physician response to the approval of sacubitril/valsartan in the USA.Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats.Selective antihypertensive dihydropyridines lower Aβ accumulation by targeting both the production and the clearance of Aβ across the blood-brain barrier.Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex.Angiotensin Receptor Blockade Modulates NFκB and STAT3 Signaling and Inhibits Glial Activation and Neuroinflammation Better than Angiotensin-Converting Enzyme Inhibition.Amlodipine treatment of hypertension associates with a decreased dementia risk.Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases.Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.Candesartan prevents impairment of recall caused by repeated stress in rats.Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study.Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSC
P2860
Q26740260-C8C2AB56-0551-40C7-9234-5A1553768885Q26861984-23A1B043-1BAA-4598-8950-7C3FB9496339Q28076516-F4ADDC35-B6C0-47BE-9F3A-5740AC05A2A8Q30410885-5AB07211-C1A9-486E-82C4-8A414D5C7131Q33604279-379D5F6F-804E-4507-B79E-3FEE1E1F7335Q33800185-75B3E51B-4287-4BB3-B1AF-D57964C695FBQ33896147-78AAC13F-FB03-49A0-A858-677BBAC1622CQ34018789-88D8EB32-E7AC-4B3D-8871-C9D33BFD388AQ34390088-876F7D2C-93F6-4928-A4A5-E05466100E1EQ34399201-CB141954-AC8C-4A80-8F20-AF08050A6E31Q34974827-E6AD6B1F-B50F-4C21-9471-444A054FC914Q35780850-A49C484A-3EF3-4CCB-8439-0FB9D16CE5A8Q36377901-27F2A49A-40DE-44E6-89F4-70BE9937911EQ36410269-10729A79-0195-4C06-90E8-D208D3118904Q36670162-97508B51-607F-4080-B4EF-14C816884EF2Q36721522-DB5C6096-3CD7-4BC4-94D1-C1615F1782E9Q36989228-2EE0B35C-14FA-4B30-BA0D-56E11E299677Q37600856-9F62ADA4-393C-426C-8B96-ED2311D59213Q37788825-0B0D324A-B54D-46D4-BB12-9927E03FE7BBQ37947688-2901EB8B-8821-4AF2-AC35-740497D69BBFQ38005611-FBB36140-D766-44D2-B2DF-8BD9E784E259Q38022265-99C7AF65-ED8F-4138-945E-03E978B26BC2Q38101981-7CD6EF70-257D-4D99-893C-9F8520971F3FQ38116974-F7554B58-3494-4E16-A89E-7160BDF4D3D2Q38237226-D7534939-C690-4A2B-B0C8-9ABDCEF31AB1Q38571859-2B98F700-E9E5-4C10-84AA-0BA2382667F9Q38781022-94A31383-B1FD-412E-AD2F-C5A0BF472741Q38924076-0151F592-C226-4BF3-A1A1-0A4A323EAE89Q38953647-93EAEF18-3485-4E41-8DAA-C43C8C5E77BEQ39618144-1D6AA90B-A9AB-4187-83BB-8395FC072DEDQ39958637-6F81613A-A848-4288-A31B-449F642FE4FDQ40032135-05459152-8437-4D26-BAC1-D76A9A034222Q40212788-F3EEC3BC-78A0-49D4-BDCE-D353963EC35EQ40661217-87AE128B-2F8E-49FC-9F09-AD28CA32282DQ41108769-28B438A9-ECBC-45F8-B53F-B840F32752D1Q42069095-88573108-BBC2-4426-A70B-F788DFFFE04CQ42533045-FDF8E591-3654-4651-8DAD-76D120C968FAQ48185429-3C9E2644-19D9-4B78-9439-FC4ECD506FA3Q48873920-2F055D28-5CFF-4A91-A3B0-6A37885AD5A2Q50771406-5BC8ABC7-8F44-4267-A77F-CE3A50045889
P2860
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention of dementia by anti ...... thiazides and ACE-inhibitors.
@en
Prevention of dementia by anti ...... thiazides and ACE-inhibitors.
@nl
type
label
Prevention of dementia by anti ...... thiazides and ACE-inhibitors.
@en
Prevention of dementia by anti ...... thiazides and ACE-inhibitors.
@nl
prefLabel
Prevention of dementia by anti ...... thiazides and ACE-inhibitors.
@en
Prevention of dementia by anti ...... thiazides and ACE-inhibitors.
@nl
P2093
P2860
P356
P1476
Prevention of dementia by anti ...... thiazides and ACE-inhibitors.
@en
P2093
Adriana Albu
Albert Fournier
François Gueyffier
Hakim Mazouz
Jean-Marie Serot
Jean-Michel Achard
Jiguang Wang
Mohamed Temmar
Naoyuki Sato
Olivier Godefroy
P2860
P304
P356
10.1586/ERN.09.89
P50
P577
2009-09-01T00:00:00Z